Skip to content
Screener

Sera Prognostics SERA EPS (Diluted)

EPS (Diluted) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$0.36
Labcorp Holdings logo
Labcorp HoldingsLH
$3.64+28.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2.84+15.0%
Natera, Inc. logo
Natera, Inc.NTRA
-$0.47+36.5%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
$0.15+850%
Revvity logo
RevvityRVTY
$0.47+2.2%

Other financials

Income statement

See full
Revenue$30.0K+76.5%
Operating income-$10.0M-7.3%
Net income-$9.1M-13.6%

Balance sheet

See full
Cash & equivalents$4.4M-12.3%
Total debt$3.0M+702%
Total equity$59.4M-32.7%
Total assets$86.7M-22.4%

Cash flow

See full
Operating cash flow-$6.3M-15.3%
CapEx$16.0K-94.3%
Free cash flow-$6.3M-10.0%

Valuation

See full
Market cap$82.45M-23.7%
Enterprise value$81.05M-21.7%
P/S1,177.9×+177×

Profitability

See full
Operating margin-53,282.9%+68,202pp
Net margin-47,475.7%+62,047pp
FCF margin-40,211.4%+69,269pp

Returns & leverage

See full
Return on equity-45%+0.8pp
Debt / equity0.1×0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Sera Prognostics’s 10-Q, filed August 12, 2026.

Filed
Aug 12, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-346862
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Interest expense(2)(2)(4)(6)
Other income, net8671,2761,8302,343
Net loss$(9,139)$(8,046)$(17,538)$(16,233)
Net loss per share, basic and diluted$(0.18)$(0.16)$(0.35)$(0.36)
Weighted-average shares outstanding, basic and diluted50,476,87449,066,39850,368,46445,536,846
Other comprehensive (loss) income:
Unrealized (loss) gain on available-for-sale debt securities, net of tax$(64)$69$(310)$85
Total other comprehensive (loss) income(64)69(310)85

Item 1. Financial Statements (Unaudited)

FAQ

What is Sera Prognostics's EPS (diluted)?
Sera Prognostics (SERA) reported EPS (diluted) of -$0.18 in Q2 2026.
How has Sera Prognostics's EPS (diluted) changed year-over-year?
Sera Prognostics's EPS (diluted) decreased by 12.5% year-over-year, from -$0.16 to -$0.18.
What is the long-term trend for Sera Prognostics's EPS (diluted)?
Over 4 years (2021 to 2025), Sera Prognostics's EPS (diluted) has grown at a -44.4% compound annual growth rate (CAGR), from -$7.12 to -$0.68.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Sera Prognostics's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude